Consistent data coming from biochemical studies have evidenced a brain-derived neurotrophic factor (BDNF) serum reduction in depressed patients compared to controls and a restoration following antidepressant treatment. However, to date, no study has evaluated whether BDNF synthesis in leukocytes could contribute to such modulation. Therefore, in this Study, we analysed BDNF mRNA levels in leukocytes from 21 depressed patients prior to and during escitalopram treatment and from 23 control subjects showing that BDNF mRNA levels were decreased in drug-free depressed patients and that 12 wk escitalopram treatment was able to reverse this deficit. Interestingly, changes in BDNF mRNA levels paralleled BDNF serum increase during antidepressant treatment, and were correlated with symptoms improvement. Our results indicate that BDNF serum modulation observed in depressed patients is associated with BDNF synthesis alteration in leukocytes and Suggest that these peripheral cells might play an active role in the mechanisms of action of antidepressants.

Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment / A. Cattaneo, L. Bocchio-Chiavetto, R. Zanardini, E. Milanesi, A. Placentino, M. Gennarelli. - In: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. - ISSN 1461-1457. - 13:1(2010 Feb), pp. 103-108. [10.1017/S1461145709990812]

Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment

A. Cattaneo
Primo
;
2010-02

Abstract

Consistent data coming from biochemical studies have evidenced a brain-derived neurotrophic factor (BDNF) serum reduction in depressed patients compared to controls and a restoration following antidepressant treatment. However, to date, no study has evaluated whether BDNF synthesis in leukocytes could contribute to such modulation. Therefore, in this Study, we analysed BDNF mRNA levels in leukocytes from 21 depressed patients prior to and during escitalopram treatment and from 23 control subjects showing that BDNF mRNA levels were decreased in drug-free depressed patients and that 12 wk escitalopram treatment was able to reverse this deficit. Interestingly, changes in BDNF mRNA levels paralleled BDNF serum increase during antidepressant treatment, and were correlated with symptoms improvement. Our results indicate that BDNF serum modulation observed in depressed patients is associated with BDNF synthesis alteration in leukocytes and Suggest that these peripheral cells might play an active role in the mechanisms of action of antidepressants.
BDNF; escitalopram; leukocytes; major depression; serum; Adolescent; Adult; Aged; Brain-Derived Neurotrophic Factor; Citalopram; Depressive Disorder, Major; Female; Gene Expression; Humans; Leukocytes; Male; Middle Aged; RNA, Messenger; Serotonin Uptake Inhibitors; Treatment Outcome
Settore BIO/14 - Farmacologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
13-1-103.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 121.46 kB
Formato Adobe PDF
121.46 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/931180
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 72
social impact